Form 4: QuidelOrtho Corp Executive Awarded Stock Options and Restricted Stock Units
SEC Form 4 Filing
Michelle A. Hodges, Chief Legal Officer of QuidelOrtho Corp, was granted stock options and restricted stock units on January 29, 2025.
Summary
- Michelle A. Hodges, Chief Legal Officer at QuidelOrtho Corp, received 23,509 restricted stock units and 23,508 non-qualified stock options on January 29, 2025.
- The restricted stock units will vest in three tranches: 15,672 shares vesting equally on January 29, 2026 and January 29, 2027, and the remaining 7,837 shares vesting on January 29, 2028.
- The non-qualified stock options will vest in equal installments on January 29, 2026, January 29, 2027, and January 29, 2028.
- The exercise price for the stock options is $43.52.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management and shareholder interests. There are no negative implications.
Positives
- The grant of stock options and restricted stock units aligns the executive's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Industry Context
This type of equity grant is a common practice for incentivizing and retaining key executives in publicly traded companies.
Comparison to Industry Standards
- Equity grants are a standard component of executive compensation packages in the healthcare and diagnostics industry.
- Companies like Abbott Laboratories (ABT) and Danaher Corporation (DHR) also use stock options and restricted stock units to align executive interests with shareholder value.
- The vesting schedule of three years is also typical for these types of grants.
Stakeholder Impact
- Shareholders may view this as a positive sign of aligning management interests with company performance.
- Employees may see this as a standard practice for executive compensation.
Key Dates
| Date | Description |
|---|---|
| 01/29/2025 | Date of the grant of restricted stock units and non-qualified stock options. |
| 01/29/2026 | First vesting date for a portion of the restricted stock units and stock options. |
| 01/29/2027 | Second vesting date for a portion of the restricted stock units and stock options. |
| 01/29/2028 | Final vesting date for the remaining restricted stock units and stock options. |
| 01/31/2025 | Date of the filing of the Form 4. |
Keywords
stock options, restricted stock units, executive compensation, insider trading, QuidelOrtho Corp, QDEL, Michelle A. Hodges
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.